공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

특수 제네릭 의약품 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년)

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 04월 상품 코드 999876
페이지 정보 영문 140 Pages
가격
US $ 2,299 ₩ 2,638,000 PDF (Single User License)
US $ 3,399 ₩ 3,900,000 PDF (5 User License)
US $ 4,499 ₩ 5,162,000 PDF (Corporate License)


특수 제네릭 의약품 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년) Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 04월 페이지 정보 : 영문 140 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 특수 제네릭 의약품 시장 규모는 2020년에 573억 달러에 달했습니다. 특수 제네릭 의약품은 특허 기한이 만료된 특수 의약품의 제네릭판입니다. 이러한 약은 암, 자가면역질환, 간질, HIV, 간염, 다발성 경화증, 류마티스 관절염 등의 만성질환 또는 합병증 치료에 사용되고 있습니다. 특수 제네릭은 고가의 개발비와 마케팅 비용을 필요로 하지 않기 때문에 브랜드 의약품과 비교해 비용 효율이 높아집니다.

기존 제네릭 의약품과 비교해 특수 제네릭 의약품 시장은 복잡한 제조 요건, 더 높은 자본 비용 및 환자수 감소에 의한 비교적 적은 양 때문에 소수의 기업에 집중하고 있습니다. 그로 인해 브랜드 의약품과 비교해 가격이 인하되고, 그 결과 기존 제네릭 의약품과 비교해 이익률이 높아집니다. 특수 제네릭 의약품은 특별한 취급, 관리, 감시가 필요하고, 보통 그것을 주문하려면 사전 승인이 필요합니다. 세계의 특수 제네릭 의약품 시장은 현재 고령화 인구 증가, 다수 브랜드 특수 의약품의 특허 만료, 암, 다발성 경화증, HIV 등 다양한 치사적인 질환의 유병률 증가, 헬스케어 프로바이더로부터의 비용 억제 대책, 신흥 시장으로부터의 성장 등이 시장 성장을 촉진하는 요인이 되고 있습니다. 세계의 특수 제네릭 의약품 시장은 향후 5년간 강력한 성장을 나타낼 것으로 예상됩니다.

세계의 특수 제네릭 의약품(Specialty Generics) 시장에 대해 조사했으며, 업계 동향, 시장 예측, 투여 경로·적응증·유통 채널·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서문

제2장 범위와 조사 방법

제3장 주요 요약

제4장 세계의 특수 제네릭 의약품 시장 : 서론

제5장 특수 제네릭 의약품이 유리한 점

제6장 세계의 특수 제네릭 의약품 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 투여 경로별 시장 세분화
  • 적응증별 시장 세분화
  • 유통 채널별 시장 세분화
  • 지역별 시장 세분화
  • SWOT 분석
    • 개요
    • 강점
    • 약점
    • 시장 기회
    • 위협
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • 주요 시장 성장 촉진요인과 성공요인

제7장 투여 경로별 시장 세분화

  • 주사제
  • 경구
  • 기타

제8장 적응증별 시장 세분화

  • 종양학
  • 자가면역질환
  • 감염증
  • 기타

제9장 유통 채널별 시장 세분화

  • 소매 약국
  • 전문 약국
  • 병원 약국

제10장 지역별 시장 세분화

  • 북미
    • 시장 개요
    • 시장 실적
    • 국가별 시장 세분화
    • 미국
    • 캐나다
  • 유럽
    • 시장 개요
    • 시장 실적
    • 국가별 시장 세분화
    • 이탈리아
    • 독일
    • 프랑스
    • 영국
    • 스페인
  • 아시아태평양
    • 시장 개요
    • 시장 실적
    • 국가별 시장 세분화
    • 일본
    • 중국
    • 인도
    • 한국
  • 라틴아메리카
    • 시장 개요
    • 시장 실적
    • 국가별 시장 세분화
    • 브라질
    • 멕시코
  • 중동 및 아프리카
    • 시장 개요
    • 시장 실적

제11장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
KSM 21.04.29

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 9: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
  • Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
  • Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
  • Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
  • Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
  • Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
  • Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
  • Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
  • Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players

The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc. Looking forward, IMARC Group expects the global specialty generics market to exhibit strong growth during the next five years.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Scope:

  • Historical, Current and Future Market Trends

Market Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:

  • The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What has been the impact of COVID-19 on the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
    • 10.1.4 United States
      • 10.1.4.1 Market Trends
      • 10.1.4.2 Market Forecast
    • 10.1.5 Canada
      • 10.1.5.1 Market Trends
      • 10.1.5.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Germany
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 France
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 United Kingdom
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
    • 10.2.8 Spain
      • 10.2.8.1 Market Trends
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
    • 10.3.4 Japan
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 China
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 India
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 South Korea
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
    • 10.4.4 Brazil
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Mexico
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.

Back to Top
전화 문의
F A Q